Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Frailty × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 NET 1 Genitourinary 1 Endocrine 1

Conditions

Neuroendocrine Tumors 148 Carcinoid Tumor 23 Carcinoma, Neuroendocrine 17 Neoplasms 13 Gastro-enteropancreatic neuroendocrine tumor 13 Adenoma, Islet Cell 13 Pancreatic Neoplasms 9 Pheochromocytoma 8 Paraganglioma 8 Neoplasm Metastasis 8 Carcinoma 7 Neuroblastoma 6 Colorectal Neoplasms 6 Sarcoma 5 Neuroectodermal Tumors, Primitive 5 Vipoma 4 Somatostatinoma 4 Small Cell Lung Carcinoma 4 Serotonin Syndrome 4 Medulloblastoma 4 Gastrointestinal Neoplasms 4 Gastrinoma 4 Cholangiocarcinoma 4 Breast Neoplasms 4 Anus Neoplasms 4 Multiple Endocrine Neoplasia 3 Mesothelioma 3 Digestive System Neoplasms 3 Diarrhea 3 Carcinoma, Non-Small-Cell Lung 3

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05554003 2024-11-18

MeTe

European Institute of Oncology

Phase 2 Recruiting

Frailty, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡